Articles tagged "Liver transplantation"

2020 American Transplant Congress
Impact of New Onset Atrial Fibrillation on Clinical Outcomes in Liver Transplant Recipients
C. M. Anugwom¹, S. Jackson², T. Pruett³, N. Lim¹
¹Gastroenterology, Hepatology and Nutrition, University of Minnesota Medical Center, Minneapolis, MN, ²Fairview Health Services., Minneapolis, MN, ³Transplant Surgery, University of Minnesota Medical Center, Minneapolis, MN
*Purpose: Atrial fibrillation (AF) is a common arrhythmia in liver transplant (LT) recipients but there continues to be a paucity of data on this topic.…
2020 American Transplant Congress
Liver Transplant Waitlist Mortality is Not Associated with Urbanicity
Y. Chen¹, Y. Hung², Y. Hsu³, C. de Crescenzo¹, C. Rickert¹, J. Adler⁴, D. Chang¹, H. Yeh¹
¹Surgery, Massachusetts General Hospital, Boston, MA, ²Surgery, Sinai Hospital of Baltimore, Baltimore, MA, ³Harvard School of Public Health, Boston, MA, ⁴Surgery, Brigham and Women's Hospital, Boston, MA
*Purpose: Because of geographic disparity in transplant rates and organ usage, distance-based liver distribution has been proposed to replace Donor Service Area based distribution. However,…
2020 American Transplant Congress
Waitlist Mortality and Transplant Probability for Inactively Listed Liver Patients Depends on Donor Service Areas’ Median MELD at Transplant
R. Batra¹, S. Noreen², D. Stewart², D. Haakinson¹, G. Gan³, Y. Deng³, S. Kulkarni¹
¹Surgery, Yale University School of Medicine, New Haven, CT, ²UNOS, Richmond, VA, ³Yale University, New Haven, CT
*Purpose: Presently, the outcome of patients listed inactive on liver transplant waiting list (WL) are unknown; as inactive patients cannot receive deceased donor organ offers,…
2020 American Transplant Congress
Early Recurrence Of Hepatocellular Carcinoma Following Transplantation: Risk Score From A Multi-institutional Study Of > 3000 Patients
P. Tabrizian¹, M. Holzner², V. Agopian³, R. Busuttil³, G. Sapisochin⁴, N. Mehta⁵, F. Yao⁵, J. Roberts⁶, S. Florman¹, M. E. Schwartz¹, T. Ivanics⁷, J. Emond⁸, B. Samstein⁹, R. Brown, MD, MPH⁹, M. Najjar¹⁰, W. Chapman¹¹, M. Doyle¹¹, K. Halazun⁹
¹Transplant, Mount Sinai Medical Center, New York, NY, ²Surgery, Georgetown University Hospital, Washington DC, MD, ³Transplant, David Geffen School of Medicine at UCLA, Los Angeles, CA, ⁴Transplant, Univeristy of Toronto, Toronto, ON, Canada, ⁵Transplant, UCSF, San Francisco, CA, ⁶Transplantation, UCSF, San Francisco, CA, ⁷Transplant, University of Toronto, Toronto, ON, Canada, ⁸Transplant, Columbia University Medical Center, New York, NY, ⁹Transplant, Weill Cornell Medical Center, New York, NY, ¹⁰Transplant, Columbia Medical Center, New York, NY, ¹¹Transplant, Washington University School of Medicine, St Louis, MO
*Purpose: Early recurrence of hepatocellular carcinoma (HCC) after liver transplantation (LT) carries a poor prognosis. We aimed to develop a risk score for early HCC…
2020 American Transplant Congress
Higher Probability of Living Donor Liver Transplantation is Associated with DSAs Having a Higher Median Meld at Transplant
D. Haakinson¹, S. Noreen², D. Stewart², R. Batra¹, G. Gan¹, Y. Deng¹, S. Kulkarni¹
¹Yale, New Haven, CT, ²UNOS, Richmond, VA
*Purpose: Recent studies show that outcomes of living donor liver transplantation (LDLT) are superior compared to those receiving deceased donor grafts. Access to deceased donor…
2020 American Transplant Congress
Human Antigen R (HuR): A New Regulator of Heme Oxygenase-1 Cytoprotection in Mouse and Human Liver Transplantation
K. J. Dery¹, K. Nakamura², K. Kadono¹, H. Hirao¹, S. Kageyama¹, T. Ito¹, H. Kojima¹, F. Kaldas¹, R. W. Busuttil¹, J. W. Kupiec-Weglinski¹
¹Department of Surgery, Division of Liver and Pancreas Transplantation, UCLA, Los Angeles, CA, ²Surgery, Nishi-Kobe Medical Center, Hyogo, Japan
*Purpose: Ischemia-reperfusion injury (IRI) represents a risk factor in liver transplantation (LT). We have shown that overexpression of heme oxygenase 1 (HO-1) mitigates hepatic IRI…
2020 American Transplant Congress
Management of Hepatic Artery Stenosis Post Liver Transplant
S. Bommena, I. Joshi, P. Kang, T. Chaly, A. Seetharam, N. Patel, M. B. Fallon, S. Mehta
Banner University Medical Center, University of Arizona College of Medicine, Phoenix, AZ
*Purpose: Hepatic Artery Stenosis (HAS) is a significant complication after liver transplantation associated with morbidity. The primary aim of this study is to determine if…
2020 American Transplant Congress
Duration of Pre-Transplant Abstinence Does Not Predict Severe Relapses of Alcohol Abuse in High-Risk Alcoholic Liver Transplant Recipients
W. H. Kitchens
Emory Transplant Center, Atlanta, GA
*Purpose: The traditional requirement of >6 months pre-transplant sobriety for liver transplant recipients has been challenged by emerging literature, but risk factors for post-transplant recidivism…
2020 American Transplant Congress
Association between Alcoholic Liver Disease and Alcohol Tax
S. Melo¹, A. Ermekbaeva², J. Buggs³, E. Rogers³, A. Kumar⁴, N. Kemmer⁵
¹School of Medicine, Indiana University, Indianapolis, IN, ²Honors College, University of South Florida, Tampa, FL, ³Transplant Surgery, Tampa General Hospital, Tampa, FL, ⁴Morsani College of Medicine, University of South Florida, Tampa, FL, ⁵Transplant Hepatology, Tampa General Hospital, Tampa, FL
*Purpose: The incidence of Alcoholic Liver Disease (ALD) has increased, causing ALD to become a primary indication for liver transplantation in the United States. We…
2020 American Transplant Congress
The Application of Electron Microscope Examination in Evaluation of Donor Liver Quality in Liver Transplantation
M. Chen¹, X. Lin², Z. Chen¹, M. Han¹, W. Ju¹, X. He¹
¹Transplant Center, First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China, ²Division of General Surgery, The East Hospital of the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
*Purpose: Liver transplantation (LT) is considered as the only curable treatment for patients with end stage liver diseases. Post-operative complications include early allograft dysfunction (EAD),…